Detalles de la búsqueda
1.
Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study.
Gynecol Obstet Invest
; 88(4): 214-225, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37369184
2.
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
Reprod Biol Endocrinol
; 19(1): 90, 2021 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134695
3.
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management.
Reprod Biol Endocrinol
; 18(1): 45, 2020 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404170
4.
A two-third majority of infertile women exhibit endometriosis in pre-ART diagnostic hysteroscopy and laparoscopic chromopertubation: only one-third have a tubal obstruction.
Arch Gynecol Obstet
; 301(4): 1081-1088, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170409
5.
Endometriosis reduces ovarian response in controlled ovarian hyperstimulation independent of AMH, AFC, and women's age measured by follicular output rate (FORT) and number of oocytes retrieved.
Arch Gynecol Obstet
; 300(6): 1759-1765, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667607
6.
The neuro control of the ovarain cycle - a hypothesis.
Gynecol Endocrinol
; 34(4): 278-282, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29171353
7.
A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.
Reprod Biol Endocrinol
; 12: 6, 2014 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24423045
8.
QS ENDO Pilot - A Study by the Stiftung Endometrioseforschung (SEF) on the Quality of Care Provided to Patients with Endometriosis in Certified Endometriosis Centers in the DACH Region.
Geburtshilfe Frauenheilkd
; 83(7): 835-842, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37404976
9.
Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study.
Gynecol Endocrinol
; 28(5): 345-50, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22115012
10.
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals.
Best Pract Res Clin Obstet Gynaecol
; 85(Pt B): 217-228, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35219590
11.
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry.
Best Pract Res Clin Obstet Gynaecol
; 85(Pt B): 188-202, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304097
12.
A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study.
Gynecol Endocrinol
; 27(9): 650-4, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20849209
13.
QS ENDO Real - A Study by the German Endometriosis Research Foundation (SEF) on the Reality of Care for Patients with Endometriosis in Germany, Austria and Switzerland.
Geburtshilfe Frauenheilkd
; 80(2): 179-189, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32109970
14.
A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany.
Int J Womens Health
; 11: 319-331, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31191040
15.
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.
Front Endocrinol (Lausanne)
; 10: 814, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31824427
16.
A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain.
J Med Econ
; 21(11): 1096-1101, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30113238
17.
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.
Fertil Steril
; 109(4): 644-664, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653717
18.
Comment to: "Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic Lesions".
Geburtshilfe Frauenheilkd
; 82(1): 93-94, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35027864
19.
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility.
Int J Womens Health
; 8: 683-689, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27994486
20.
Managing infertility with the follitropin alfa prefilled pen injector - patient considerations.
Ther Clin Risk Manag
; 11: 995-1001, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26170678